Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
상품코드:1621146
리서치사:BCC Research
발행일:2024년 12월
페이지 정보:영문 130 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 실험 동물 모델, 3D배양, 오가노이드 시장 규모는 2024년 28억 달러에서 예측기간 동안 CAGR 12.5%로 추이하고 2029년 50억 달러에 달할 것으로 예측되고 있습니다.
동물 모델 부문은 2024년 18억 달러에서 예측 기간 동안 CAGR 12.2%로 추이하고, 2029년에는 32억 달러에 달할 것으로 예측되고 있습니다. 3D 세포 배양 부문은 2024년 10억 달러에서 CAGR 13.2%로 성장을 지속하여 2029년에는 19억 달러에 이를 것으로 예측됩니다.
이 보고서는 세계 실험 동물 모델, 3D 배양, 유기농 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 분석
제2장 시장 개요
개요
Porter's Five Forces 분석
제3장 시장 역학
개요
시장 성장 촉진요인
동물실험의 윤리적 대체법에 주목
종양 모델링과 바이오뱅킹 수요 증가
오가노이드 기술의 폭넓은 용도에의 채용 확대
시장 성장 억제요인
세포 배양과 줄기세포의 연구개발을 규제하는 엄격한 정부규제
오가노이드를 기존의 조사 방법에 통합할 때의 과제
시장 기회
의약품 개발, 맞춤형 의료, 이식에의 응용
제4장 규제 상황
규제 시나리오
미국
유럽연합
영국
독일
인도
제5장 신기술
개요
3D 프린팅
마이크로플루이딕스
AI와 자동화
특허 분석
제6장 시장 세분화 분석
세분화의 내역
세계의 실험 동물 모델·3D 배양·오가노이드 시장 :동물 모델별
동물 모델
세계 시장 규모와 예측
마우스
쥐
토끼
햄스터
기니피그
기타
세계의 실험 동물 모델·3D 배양·오가노이드 시장 :3D 배양별
3D 배양
세계 시장 규모와 예측
장기 온칩
오가노이드
장
간
위
췌장
폐
신장
기타
스페로이드
세계의 실험 동물 모델·3D 배양·오가노이드 시장 :용도별
발생 생물학
창약과 맞춤형 의료
재생 의료
감염증의 병리학
약물의 독성과 효능의 시험
기타
지리적 내역
세계의 실험 동물 모델·3D 배양·오가노이드 시장 :지역별
세계 시장 규모와 예측
북미
미국
캐나다
시장 규모와 예측
유럽
독일
영국
시장 규모와 예측
아시아태평양
기타 지역
제7장 경쟁 정보
경쟁 구도
전략 분석
제8장 실험 동물 모델·3D 배양·오가노이드에 있어서의 지속가능성:ESG의 관점
ESG: 소개
시장에서의 지속가능성
ESG의 관점
환경에 미치는 영향
사회적 영향
거버넌스
제9장 부록
조사 방법
약어
출처
기업 프로파일
3D BIOTEK LLC.
BIO-TECHNE
CELLINK
CHARLES RIVER LABORATORIES
CHERRY BIOTECH
CORNING INC.
EMULATE
GENOWAY
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
MATTEK
MIMETAS BV
PEPGEL LLC.
POIETIS
TACONIC BIOSCIENCES INC.
THEWELL BIOSCIENCE INC.
THERMO FISHER SCIENTIFIC INC.
JHS
영문 목차
영문목차
The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
The animal model market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.8 billion in 2024 to reach $3.2 billion by 2029, at a CAGR of 12.2% from 2024 through 2029.
The 3D cell culture market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.0 billion in 2024 to reach $1.9 billion by 2029, at a CAGR of 13.2% from 2024 through 2029.
Report Scope
The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.
This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.
This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.
The report's goals include:
Analyzing product types and applications.
Analyzing global market size and segmentation.
Understanding market constraints and drivers.
Providing detailed market forecasts up to 2029.
Assessing market shares, competitiveness, and industry structure.
Identifying potential long-term impacts on the market.
Report Includes
45 data tables and 52 additional tables
An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region
Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
Review of selected patents and patent applications on organoids, and emerging developments in the global market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies
A discussion of ESG challenges and practices in the industry
Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Overview
Market Drivers
Growing Focus on Ethical Alternatives to Animal Testing
Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion
Increasing Adoption of Organoid Technology for Wider Applications
Market Restraints
Strict Government Regulations Governing Cell Cultures and Stem Cells R&D
Challenges in Incorporating Organoids into Existing Research Practices
Market Opportunities
Applications in Drug Development, Personalized Medicine, and Transplantation
Chapter 4 Regulatory Landscape
Regulatory Scenarios
United States
EU
U.K.
Germany
India
Chapter 5 Emerging Technologies
Overview
3D Printing
Microfluidics
Artificial Intelligence and Automation
Patent Analysis
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model
Animal Models
Global Market Size and Forecast
Mice
Rats
Rabbits
Hamsters
Guinea Pigs
Others
Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures
3D Cultures
Global Market Size and Forecast
Organ-on-chip
Organoids
Intestine
Liver
Stomach
Pancreas
Lung
Kidney
Others
Spheroids
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application
Developmental Biology
Drug Discovery and Personalized Medicine
Regenerative Medicine
Pathology of Infectious Disease
Drug Toxicity and Efficacy Testing
Others
Geographic Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region
Global Market Size and Forecast
North America
U.S.
Canada
Market Size and Forecast
Europe
Germany
U.K.
Market Size and Forecast
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Competitive Landscape
Strategic Analysis
Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective
